Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Pulmonary drug delivery systems are used to the treatment of various respiratory diseases like asthma and chronic obstructive pulmonary disease (COPD), delivering locally acting drugs directly to their site of action. Advantages of pulmonary drug delivery systems over oral drugs is the excellent capability of absorbing pharmaceuticals, due to the large absorptive surface area of lungs (approximately 70-140 m2 in adult humans having extremely thin absorptive mucosal membrane) and good blood supply.
With better performance, the development of DPIs is faster than the MDIs. In the future, DPIs will occupy larger market share and replace the MDIs gradually. In addition, the market share of nebulizers will be smaller.As WHO said, the COPD will become the world's third-leading cause of death by 2030. With the air pollution more and more serious, patients with respiratory diseases will be more and more, which means larger and larger demand for pulmonary drug delivery systems.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Pulmonary Drug Delivery Systems market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Pulmonary Drug Delivery Systems market. Detailed analysis of key players, along with key growth strategies adopted by Pulmonary Drug Delivery Systems industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Cipla
Taian Character
Chiesi
Skyepharma
AstraZeneca
GSK
Chia Tai Tianqing
3M
Novartis
PARI
Philips Respironics
Aptar
Shanghai Huarui
Omron Healthcare
CareFusion
Boehringer Ingelheim
By Type:
Nebulizers
Dry Powder Inhaler (DPI)
Metered Dose Inhaler (MDI)
By End-User:
COPD
Asthma
Others
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Pulmonary Drug Delivery Systems Market
-
1.3 Market Segment by Type
-
1.3.1 USA Pulmonary Drug Delivery Systems Market Size and Growth Rate of Nebulizers from 2016 to 2027
-
1.3.2 USA Pulmonary Drug Delivery Systems Market Size and Growth Rate of Dry Powder Inhaler (DPI) from 2016 to 2027
-
1.3.3 USA Pulmonary Drug Delivery Systems Market Size and Growth Rate of Metered Dose Inhaler (MDI) from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Pulmonary Drug Delivery Systems Market Size and Growth Rate of COPD from 2016 to 2027
-
1.4.2 USA Pulmonary Drug Delivery Systems Market Size and Growth Rate of Asthma from 2016 to 2027
-
1.4.3 USA Pulmonary Drug Delivery Systems Market Size and Growth Rate of Others from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Pulmonary Drug Delivery Systems Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Pulmonary Drug Delivery Systems Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Pulmonary Drug Delivery Systems Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Pulmonary Drug Delivery Systems Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Pulmonary Drug Delivery Systems Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Pulmonary Drug Delivery Systems by Major Types
-
3.4.1 Market Size and Growth Rate of Nebulizers
-
3.4.2 Market Size and Growth Rate of Dry Powder Inhaler (DPI)
-
3.4.3 Market Size and Growth Rate of Metered Dose Inhaler (MDI)
4 Segmentation of Pulmonary Drug Delivery Systems Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Pulmonary Drug Delivery Systems by Major End-Users
-
4.4.1 Market Size and Growth Rate of Pulmonary Drug Delivery Systems in COPD
-
4.4.2 Market Size and Growth Rate of Pulmonary Drug Delivery Systems in Asthma
-
4.4.3 Market Size and Growth Rate of Pulmonary Drug Delivery Systems in Others
5 Market Analysis by Regions
-
5.1 USA Pulmonary Drug Delivery Systems Production Analysis by Regions
-
5.2 USA Pulmonary Drug Delivery Systems Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Pulmonary Drug Delivery Systems Landscape Analysis
-
6.1 West USA Pulmonary Drug Delivery Systems Landscape Analysis by Major Types
-
6.2 West USA Pulmonary Drug Delivery Systems Landscape Analysis by Major End-Users
7 South USA Pulmonary Drug Delivery Systems Landscape Analysis
-
7.1 South USA Pulmonary Drug Delivery Systems Landscape Analysis by Major Types
-
7.2 South USA Pulmonary Drug Delivery Systems Landscape Analysis by Major End-Users
8 Middle West USA Pulmonary Drug Delivery Systems Landscape Analysis
-
8.1 Middle West USA Pulmonary Drug Delivery Systems Landscape Analysis by Major Types
-
8.2 Middle West USA Pulmonary Drug Delivery Systems Landscape Analysis by Major End-Users
9 Northeast USA Pulmonary Drug Delivery Systems Landscape Analysis
-
9.1 Northeast USA Pulmonary Drug Delivery Systems Landscape Analysis by Major Types
-
9.2 Northeast USA Pulmonary Drug Delivery Systems Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Cipla
-
10.1.1 Cipla Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Taian Character
-
10.2.1 Taian Character Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Chiesi
-
10.3.1 Chiesi Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Skyepharma
-
10.4.1 Skyepharma Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 AstraZeneca
-
10.5.1 AstraZeneca Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 GSK
-
10.6.1 GSK Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 Chia Tai Tianqing
-
10.7.1 Chia Tai Tianqing Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 3M
-
10.8.1 3M Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
-
10.9 Novartis
-
10.9.1 Novartis Company Profile and Recent Development
-
10.9.2 Market Performance
-
10.9.3 Product and Service Introduction
-
10.10 PARI
-
10.10.1 PARI Company Profile and Recent Development
-
10.10.2 Market Performance
-
10.10.3 Product and Service Introduction
-
10.11 Philips Respironics
-
10.11.1 Philips Respironics Company Profile and Recent Development
-
10.11.2 Market Performance
-
10.11.3 Product and Service Introduction
-
10.12 Aptar
-
10.12.1 Aptar Company Profile and Recent Development
-
10.12.2 Market Performance
-
10.12.3 Product and Service Introduction
-
10.13 Shanghai Huarui
-
10.13.1 Shanghai Huarui Company Profile and Recent Development
-
10.13.2 Market Performance
-
10.13.3 Product and Service Introduction
-
10.14 Omron Healthcare
-
10.14.1 Omron Healthcare Company Profile and Recent Development
-
10.14.2 Market Performance
-
10.14.3 Product and Service Introduction
-
10.15 CareFusion
-
10.15.1 CareFusion Company Profile and Recent Development
-
10.15.2 Market Performance
-
10.15.3 Product and Service Introduction
-
10.16 Boehringer Ingelheim
-
10.16.1 Boehringer Ingelheim Company Profile and Recent Development
-
10.16.2 Market Performance
-
10.16.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Pulmonary Drug Delivery Systems Market Size and Growth Rate of Nebulizers from 2016 to 2027
-
Figure USA Pulmonary Drug Delivery Systems Market Size and Growth Rate of Dry Powder Inhaler (DPI) from 2016 to 2027
-
Figure USA Pulmonary Drug Delivery Systems Market Size and Growth Rate of Metered Dose Inhaler (MDI) from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Pulmonary Drug Delivery Systems Market Size and Growth Rate of COPD from 2016 to 2027
-
Figure USA Pulmonary Drug Delivery Systems Market Size and Growth Rate of Asthma from 2016 to 2027
-
Figure USA Pulmonary Drug Delivery Systems Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Pulmonary Drug Delivery Systems Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Pulmonary Drug Delivery Systems Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Pulmonary Drug Delivery Systems Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Pulmonary Drug Delivery Systems Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Pulmonary Drug Delivery Systems Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Pulmonary Drug Delivery Systems
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Pulmonary Drug Delivery Systems by Different Types from 2016 to 2027
-
Table Consumption Share of Pulmonary Drug Delivery Systems by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Nebulizers
-
Figure Market Size and Growth Rate of Dry Powder Inhaler (DPI)
-
Figure Market Size and Growth Rate of Metered Dose Inhaler (MDI)
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Pulmonary Drug Delivery Systems by Different End-Users from 2016 to 2027
-
Table Consumption Share of Pulmonary Drug Delivery Systems by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of COPD
-
Figure Market Size and Growth Rate of Asthma
-
Figure Market Size and Growth Rate of Others
-
Table USA Pulmonary Drug Delivery Systems Production by Regions
-
Table USA Pulmonary Drug Delivery Systems Production Share by Regions
-
Figure USA Pulmonary Drug Delivery Systems Production Share by Regions in 2016
-
Figure USA Pulmonary Drug Delivery Systems Production Share by Regions in 2021
-
Figure USA Pulmonary Drug Delivery Systems Production Share by Regions in 2027
-
Table USA Pulmonary Drug Delivery Systems Consumption by Regions
-
Table USA Pulmonary Drug Delivery Systems Consumption Share by Regions
-
Figure USA Pulmonary Drug Delivery Systems Consumption Share by Regions in 2016
-
Figure USA Pulmonary Drug Delivery Systems Consumption Share by Regions in 2021
-
Figure USA Pulmonary Drug Delivery Systems Consumption Share by Regions in 2027
-
Table West USA Pulmonary Drug Delivery Systems Consumption by Types from 2016 to 2027
-
Table West USA Pulmonary Drug Delivery Systems Consumption Share by Types from 2016 to 2027
-
Figure West USA Pulmonary Drug Delivery Systems Consumption Share by Types in 2016
-
Figure West USA Pulmonary Drug Delivery Systems Consumption Share by Types in 2021
-
Figure West USA Pulmonary Drug Delivery Systems Consumption Share by Types in 2027
-
Table West USA Pulmonary Drug Delivery Systems Consumption by End-Users from 2016 to 2027
-
Table West USA Pulmonary Drug Delivery Systems Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Pulmonary Drug Delivery Systems Consumption Share by End-Users in 2016
-
Figure West USA Pulmonary Drug Delivery Systems Consumption Share by End-Users in 2021
-
Figure West USA Pulmonary Drug Delivery Systems Consumption Share by End-Users in 2027
-
Table South USA Pulmonary Drug Delivery Systems Consumption by Types from 2016 to 2027
-
Table South USA Pulmonary Drug Delivery Systems Consumption Share by Types from 2016 to 2027
-
Figure South USA Pulmonary Drug Delivery Systems Consumption Share by Types in 2016
-
Figure South USA Pulmonary Drug Delivery Systems Consumption Share by Types in 2021
-
Figure South USA Pulmonary Drug Delivery Systems Consumption Share by Types in 2027
-
Table South USA Pulmonary Drug Delivery Systems Consumption by End-Users from 2016 to 2027
-
Table South USA Pulmonary Drug Delivery Systems Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Pulmonary Drug Delivery Systems Consumption Share by End-Users in 2016
-
Figure South USA Pulmonary Drug Delivery Systems Consumption Share by End-Users in 2021
-
Figure South USA Pulmonary Drug Delivery Systems Consumption Share by End-Users in 2027
-
Table Middle West USA Pulmonary Drug Delivery Systems Consumption by Types from 2016 to 2027
-
Table Middle West USA Pulmonary Drug Delivery Systems Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Pulmonary Drug Delivery Systems Consumption Share by Types in 2016
-
Figure Middle West USA Pulmonary Drug Delivery Systems Consumption Share by Types in 2021
-
Figure Middle West USA Pulmonary Drug Delivery Systems Consumption Share by Types in 2027
-
Table Middle West USA Pulmonary Drug Delivery Systems Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Pulmonary Drug Delivery Systems Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Pulmonary Drug Delivery Systems Consumption Share by End-Users in 2016
-
Figure Middle West USA Pulmonary Drug Delivery Systems Consumption Share by End-Users in 2021
-
Figure Middle West USA Pulmonary Drug Delivery Systems Consumption Share by End-Users in 2027
-
Table Northeast USA Pulmonary Drug Delivery Systems Consumption by Types from 2016 to 2027
-
Table Northeast USA Pulmonary Drug Delivery Systems Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Pulmonary Drug Delivery Systems Consumption Share by Types in 2016
-
Figure Northeast USA Pulmonary Drug Delivery Systems Consumption Share by Types in 2021
-
Figure Northeast USA Pulmonary Drug Delivery Systems Consumption Share by Types in 2027
-
Table Northeast USA Pulmonary Drug Delivery Systems Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Pulmonary Drug Delivery Systems Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Pulmonary Drug Delivery Systems Consumption Share by End-Users in 2016
-
Figure Northeast USA Pulmonary Drug Delivery Systems Consumption Share by End-Users in 2021
-
Figure Northeast USA Pulmonary Drug Delivery Systems Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Cipla
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cipla
-
Figure Sales and Growth Rate Analysis of Cipla
-
Figure Revenue and Market Share Analysis of Cipla
-
Table Product and Service Introduction of Cipla
-
Table Company Profile and Development Status of Taian Character
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Taian Character
-
Figure Sales and Growth Rate Analysis of Taian Character
-
Figure Revenue and Market Share Analysis of Taian Character
-
Table Product and Service Introduction of Taian Character
-
Table Company Profile and Development Status of Chiesi
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Chiesi
-
Figure Sales and Growth Rate Analysis of Chiesi
-
Figure Revenue and Market Share Analysis of Chiesi
-
Table Product and Service Introduction of Chiesi
-
Table Company Profile and Development Status of Skyepharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Skyepharma
-
Figure Sales and Growth Rate Analysis of Skyepharma
-
Figure Revenue and Market Share Analysis of Skyepharma
-
Table Product and Service Introduction of Skyepharma
-
Table Company Profile and Development Status of AstraZeneca
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca
-
Figure Sales and Growth Rate Analysis of AstraZeneca
-
Figure Revenue and Market Share Analysis of AstraZeneca
-
Table Product and Service Introduction of AstraZeneca
-
Table Company Profile and Development Status of GSK
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GSK
-
Figure Sales and Growth Rate Analysis of GSK
-
Figure Revenue and Market Share Analysis of GSK
-
Table Product and Service Introduction of GSK
-
Table Company Profile and Development Status of Chia Tai Tianqing
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Chia Tai Tianqing
-
Figure Sales and Growth Rate Analysis of Chia Tai Tianqing
-
Figure Revenue and Market Share Analysis of Chia Tai Tianqing
-
Table Product and Service Introduction of Chia Tai Tianqing
-
Table Company Profile and Development Status of 3M
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of 3M
-
Figure Sales and Growth Rate Analysis of 3M
-
Figure Revenue and Market Share Analysis of 3M
-
Table Product and Service Introduction of 3M
-
Table Company Profile and Development Status of Novartis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis
-
Figure Sales and Growth Rate Analysis of Novartis
-
Figure Revenue and Market Share Analysis of Novartis
-
Table Product and Service Introduction of Novartis
-
Table Company Profile and Development Status of PARI
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of PARI
-
Figure Sales and Growth Rate Analysis of PARI
-
Figure Revenue and Market Share Analysis of PARI
-
Table Product and Service Introduction of PARI
-
Table Company Profile and Development Status of Philips Respironics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Philips Respironics
-
Figure Sales and Growth Rate Analysis of Philips Respironics
-
Figure Revenue and Market Share Analysis of Philips Respironics
-
Table Product and Service Introduction of Philips Respironics
-
Table Company Profile and Development Status of Aptar
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Aptar
-
Figure Sales and Growth Rate Analysis of Aptar
-
Figure Revenue and Market Share Analysis of Aptar
-
Table Product and Service Introduction of Aptar
-
Table Company Profile and Development Status of Shanghai Huarui
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shanghai Huarui
-
Figure Sales and Growth Rate Analysis of Shanghai Huarui
-
Figure Revenue and Market Share Analysis of Shanghai Huarui
-
Table Product and Service Introduction of Shanghai Huarui
-
Table Company Profile and Development Status of Omron Healthcare
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Omron Healthcare
-
Figure Sales and Growth Rate Analysis of Omron Healthcare
-
Figure Revenue and Market Share Analysis of Omron Healthcare
-
Table Product and Service Introduction of Omron Healthcare
-
Table Company Profile and Development Status of CareFusion
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of CareFusion
-
Figure Sales and Growth Rate Analysis of CareFusion
-
Figure Revenue and Market Share Analysis of CareFusion
-
Table Product and Service Introduction of CareFusion
-
Table Company Profile and Development Status of Boehringer Ingelheim
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boehringer Ingelheim
-
Figure Sales and Growth Rate Analysis of Boehringer Ingelheim
-
Figure Revenue and Market Share Analysis of Boehringer Ingelheim
-
Table Product and Service Introduction of Boehringer Ingelheim
-
